EarningsQ2 2026 Earnings Report
MX:KMB Q2 2026 EPS Results
Actual EPS$38.78
Consensus EPS$36.74
Beat/MissBeat by +$2.05
One Year Ago EPS$35.13
MX:KMB Q2 2026 Revenue Results
Actual Revenue$76.64B
Expected Revenue$77.29B
Beat/MissMissed by -$652.42M
YoY Revenue Growth+0.62%
Earnings Announcement Details
QuarterQ2 2026
Date08/04/2026
TimeBefore Open
Conference CallTuesday, August 4, 2026
MX:KMB Upcoming Earnings
Kimberly Clark's next earnings date is estimated for October 27, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:KMB Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Neutral
The call balanced operational and strategic strengths against several meaningful near-term headwinds. Positives included sustained volume-plus-mix momentum (10 consecutive quarters), industry-leading productivity (6.4%), a $45M tariff refund that boosted Q2 operating profit and EPS, progress on Arbex and Kenvue integration, and a compelling innovation roadmap highlighted by an alternative natural fiber program. Offsetting those strengths were discrete and material challenges: a China diaper disruption (noted as significant and causing quarterly basis-point impacts), retailer destocking and an LA distribution-center fire that pressured North America shipments, a moderating category growth backdrop, elevated input-cost headwinds (~$150M in H2), and increased promotional/competitive intensity. Management expects to mitigate inflationary impacts and remains confident in long-term prospects, but near-term visibility (including 2027 cadence) is limited.Company Guidance
Sustained Volume + Mix Momentum
Delivered 10th consecutive quarter of positive volume plus mix performance; sustained positive trailing performance with volume/mix-led growth in 8 of the last 10 quarters in North America and trailing 12-month category growth ~2%.
Strong Productivity
Posted industry-leading gross productivity of 6.4% in the quarter, which materially offset higher brand investment and contributed to adjusted operating profit and EPS coming in ahead of expectations.
Tariff Refund Boost
Received a $45 million tariff refund in Q2 (roughly half of what was paid in North America), a discrete benefit that helped deliver better-than-expected operating profit and EPS for the quarter.
Share and Channel Performance
Held global weighted share; ~70% of sales were up or even on the old cohort approach; in North America the company has gained share in ~70% of its sales base and gained share in key tissue launches (e.g., Viva +80 bps in Q2).
Innovation & Pipeline Strength
Announced a proprietary alternative natural fiber program (pilot facility and thousands of acres secured) with potential to improve product softness/strength economics, reduce forest-fiber exposure and advance forest-fiber-free ambitions; management emphasized a large, multi-year innovation pipeline and accelerated commercial activation.
Strategic Transactions Progressing
Completed successful launch of Arbex JV with Suzano; making strong progress on Kenvue integration planning with bottom-up synergy planning (citing increased confidence in path to the $1.9B cost synergy target and an active cross-company integration effort).
Tissue & E‑commerce Strength
Tissue brands (Kleenex, Viva) performed well with format and activation gains; e-commerce continued to perform strongly and is a growth channel for the company.
Inflation Mitigation Toolkit
Management expects to offset incremental second-half gross input cost headwinds (~$150M) through mitigating actions, productivity and the tariff refund, targeting pricing net of cost inflation roughly neutral for the full year.
Supply Chain Restructuring Firepower
Ongoing $2 billion North America supply-chain restructuring investment provides additional productivity and margin improvement runway that management cites as 'firepower' to manage inflation and margin pressure into 2027.
MX:KMB Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed